Baillie Gifford acquired 1.16 Million Inspire Medical Systems shares worth $151 Million. That's 0.11% of their equity portfolio (108th largest holding). The investor owns 3.90% of the outstanding Inspire Medical Systems stock. The first Inspire Medical Systems trade was made in Q4 2020. Since then Baillie Gifford bought shares seven more times and sold shares on eight occasions. The investor's estimated purchase price is $196 Million, resulting in a loss of 23%.